SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,776 | -6.9% | 3,364 | +5.6% | 0.00% | 0.0% |
| Q2 2023 | $83,511 | +49.1% | 3,185 | +47.9% | 0.00% | +33.3% |
| Q4 2022 | $56,026 | +3.0% | 2,154 | +13.0% | 0.00% | 0.0% |
| Q3 2022 | $54,378 | +15.9% | 1,906 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $46,926 | -56.4% | 1,906 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $107,575 | -76.7% | 1,906 | -74.4% | 0.00% | -33.3% |
| Q4 2021 | $460,821 | -10.1% | 7,435 | -8.0% | 0.01% | -14.3% |
| Q3 2021 | $512,532 | +8.2% | 8,079 | +25.5% | 0.01% | 0.0% |
| Q1 2021 | $473,717 | -1.9% | 6,439 | -3.3% | 0.01% | 0.0% |
| Q4 2020 | $482,693 | +52.1% | 6,656 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $317,292 | +13.5% | 6,656 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $279,552 | +193.8% | 6,656 | +88.9% | 0.01% | +150.0% |
| Q1 2020 | $95,148 | -57.8% | 3,524 | -39.9% | 0.00% | -50.0% |
| Q4 2019 | $225,551 | – | 5,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |